Literature DB >> 24767672

Utility of reassessment after neoadjuvant therapy and difficulties in interpretation.

M-A Pierredon-Foulongne1, S Nougaret2, F Bibeau3, P Rouanet4, E Delhom2, J Lonjon2, N Ragu2, J Colleau2, V Schembri2, B Guiu5, B Gallix2.   

Abstract

We describe the main tools for MR assessment of the response of rectal cancer tumors after chemotherapy, before surgery. In locally advanced cases of rectal and lower rectal cancer, MR is useful in allowing the treatment strategy to be adjusted, enabling conservative surgery to be performed if the patient responds well. The different types of response (fibrous, desmoplastic and colloid), their appearances and difficulties in MR interpretation are described. We describe the features and performance of MR after neoadjuvant therapy for T and N staging, assessment of circumferential resection margin and diffusion weighted imaging. Quantitative (change in tumor volume) and qualitative (grade of tumor response) MR assessment can distinguish good responders from poor responders.
Copyright © 2014 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; MR; Neoadjuvant therapy; Rectum; Response

Mesh:

Year:  2014        PMID: 24767672     DOI: 10.1016/j.diii.2014.03.010

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  4 in total

1.  Stage cT3 low rectal cancer: analysis of prognostic factors.

Authors:  Fan Li; Jin-Hai Chen; Yang Liu; Guo-Xian Guan; Chuan-Hui Lu
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

Authors:  R García-Carbonero; R Vera; F Rivera; E Parlorio; M Pagés; E González-Flores; C Fernández-Martos; M Á Corral; R Bouzas; F Matute
Journal:  Clin Transl Oncol       Date:  2016-05-20       Impact factor: 3.405

3.  MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study.

Authors:  T Koëter; S G C van Elderen; G F A J B van Tilborg; J H W de Wilt; D K Wasowicz; T Rozema; D D E Zimmerman
Journal:  Radiat Oncol       Date:  2020-03-02       Impact factor: 3.481

4.  The Role of Magnetic Resonance Imaging in (Future) Cancer Staging: Note the Nodes.

Authors:  Tom W J Scheenen; Patrik Zamecnik
Journal:  Invest Radiol       Date:  2021-01       Impact factor: 10.065

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.